19382-49-1

Usage

Uses

Used in Pharmaceutical Industry:
3-(2-aminoethyl)thiazolidine-2,4-dione hydrochloride is used as an antidiabetic medication for the treatment of type 2 diabetes. It is utilized to improve insulin resistance, which is a key factor in the development of the disease. 3-(2-aminoethyl)thiazolidine-2,4-dione hydrochloride aids in lowering blood sugar levels by increasing the body's sensitivity to insulin, and it is often prescribed in conjunction with other diabetes medications to achieve better control of blood glucose levels.
Additionally, 3-(2-aminoethyl)thiazolidine-2,4-dione hydrochloride is used as a therapeutic agent for managing dyslipidemia in type 2 diabetes patients. It helps in reducing triglyceride levels and increasing HDL cholesterol levels, contributing to a better lipid profile and overall cardiovascular health.
However, it is important to note that the use of 3-(2-aminoethyl)thiazolidine-2,4-dione hydrochloride may be accompanied by potential side effects such as weight gain, fluid retention, and an increased risk of heart failure. Therefore, it is crucial for healthcare providers to carefully consider the benefits and risks when prescribing this medication to patients with type 2 diabetes.

InChI:InChI=1/C5H8N2O2S/c6-1-2-7-4(8)3-10-5(7)9/h1-3,6H2

Upstream product

• 96-45-7 N,N'-ethylenethiourea 
• 590-02-3 butyl chloroacetate 
• 79-11-8 chloroacetic acid 
• 91774-37-7 ethyl [(4,5-dihydro-2-imidazolyl)thio]acetate hydrochloride 

Relevant academic research and scientific papers

New data on the alkylation of cyclic thioureas with α-halocarboxylic acids and their esters. 1. Alkylation of ethylene thiourea

The detailed scheme of reactions, occurring on interacting ethylene thiourea with chloroacetic acid and its esters, has been supplemented with a series of new reactions. The whole spectrum of products formed on interaction of ethylene thiourea with 2-bromobutyric acid has been obtained. 2006 Springer Science+Business Media, Inc.